Immunotherapy Targets in Tumors
Ontology highlight
ABSTRACT: Recent work has shown that cytotoxic T cells play a central role in immune-mediated control of cancers1-3, and monoclonal antibodies that target inhibitory receptors on T cells can induce significant clinical benefit in patients despite advanced disease4-6. However, many of the regulatory pathways that result in loss of T cell function within immunosuppressive tumors remain unknown. Here we show that such regulatory mechanisms can be systematically discovered in vivo in the tumor microenvironment. We devised a pool shRNA screening approach aimed at identifying genes that block the function of tumor-infiltrating CD8 T cells. We postulated that shRNAs targeting key inhibitors would enable robust T cell infiltration and proliferation in tumors, despite multiple inhibitory signals. Candidate s
ORGANISM(S): Mus musculus
SUBMITTER: John Walker
PROVIDER: E-GEOD-53388 | biostudies-arrayexpress |
REPOSITORIES: biostudies-arrayexpress
ACCESS DATA